Pfizer Inc (MIL:1PFE)
€ 24.625 -0.16 (-0.65%) Market Cap: 138.78 Bil Enterprise Value: 192.52 Bil PE Ratio: 34.89 PB Ratio: 1.59 GF Score: 64/100

Pfizer Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript

Dec 01, 2022 / 09:20PM GMT
Umer Raffat
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research

Okay. Well, my last session, my last fireside for our 2022 Healthcare Conference. Pleasure to have Pfizer management join us. I'll turn it over to our old friend, Chris, from the buy side to kick things off and introduce the management.

Christopher J. Stevo
Pfizer Inc. - Senior VP & Chief IR Officer

Thanks so much, Umer. So I'm very pleased to introduce you to my colleagues, Angela Hwang. She's our Chief Commercial Officer and President of the Global Biopharmaceutical business; Kevin Sullivan, the President of our Specialty Care business. And finally, Navin Katyal, who's the Head of our mRNA business, especially focusing on mRNA vaccines. So thank you for your time and for your kind introduction.

Umer Raffat
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research

Outstanding. Angela, perhaps it would be great if you could kick things off and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot